Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study

Jordan University of Science and Technology

Status: Completed

Conditions: Chronic Kidney Disease(CKD)

Treatments: Other: Medication reconciliation service

Study type: Interventional

Funder types: Other

Identifiers

NCT06819527

Grant number: 20220257

Details and patient eligibility

About

This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.

Enrollment: 323 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult (18 years or older) admitted patients with CKD (stages 2-5 ), who were using at least three chronic medicines at home, and were hospitalized for at least 48 hours.

Exclusion criteria

• Patients with kidney transplantation .
• Patients who have difficulties in responding to interviews and did not have family member or caregiver on behave.
• Patients who refused to provide a written informed consent.

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Sequential Assignment

Masking: None (Open label)

---

323 participants in 2 patient groups

Intervention group

Experimental group

Description:

interventional group, in which patients received a supplemented medication reconciliation service.

Treatment:

Other: Medication reconciliation service

Retrospective control group in which patients received the usual care

No Intervention group

Description:

A retrospective control group in which patients received the usual care that may or may not include medication reconciliation